Table 5.
Characteristics of Patients Initiating a Statin Following an MI Hospitalization in 2007–2014
| Calendar Year | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |
| n | 20 816 | 24 125 | 24 495 | 25 456 | 26 556 | 26 310 | 26 378 | 27 437 |
| Age, % | ||||||||
| 21–44 y | 2.7 | 2.8 | 3.1 | 3.5 | 3.3 | 3.1 | 3.0 | 2.2 |
| 45–54 y | 9.1 | 8.5 | 10.2 | 10.4 | 10.7 | 9.4 | 8.6 | 6.6 |
| 55–64 y | 13.8 | 12.5 | 14.7 | 16.2 | 16.2 | 14.6 | 13.4 | 11.1 |
| 66–70 y | 17.3 | 18.0 | 17.0 | 16.4 | 16.5 | 17.6 | 18.6 | 20.0 |
| 71–75 y | 15.8 | 16.6 | 15.7 | 15.6 | 15.8 | 16.7 | 17.4 | 18.7 |
| 76–80 y | 15.7 | 15.8 | 14.3 | 13.6 | 13.0 | 13.5 | 13.9 | 15.3 |
| 81–85 y | 13.4 | 13.6 | 12.5 | 12.0 | 12.0 | 12.4 | 12.1 | 12.6 |
| ≥86 y | 12.3 | 12.3 | 12.4 | 12.3 | 12.5 | 12.8 | 12.9 | 13.4 |
| Male sex, % | 51.9 | 51.8 | 52.7 | 53.8 | 53.8 | 53.1 | 53.7 | 52.9 |
| Race/ethnicity, %* | ||||||||
| White | 86.8 | 87.9 | 87.2 | 87.9 | 87.0 | 87.2 | 87.5 | 88.4 |
| Black | 7.1 | 6.8 | 7.0 | 6.5 | 7.2 | 7.0 | 6.8 | 6.6 |
| Asian American | 1.9 | 1.6 | 1.9 | 1.8 | 1.7 | 1.6 | 1.8 | 1.4 |
| Hispanic | 2.5 | 2.0 | 2.3 | 2.2 | 2.1 | 2.1 | 1.9 | 1.5 |
| Other | 1.7 | 1.7 | 1.6 | 1.6 | 2.0 | 2.1 | 2.0 | 2.2 |
| Initiation of high‐intensity statin, % | 27.7 | 27.6 | 28.6 | 28.2 | 27.4 | 35.3 | 41.8 | 53.2 |
| Preindex statin fill characteristics, % | ||||||||
| History of CHD | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| History of DM | 27.2 | 27.4 | 26.7 | 26.9 | 28.0 | 28.2 | 28.0 | 28.3 |
| History of stroke | 2.5 | 2.2 | 2.2 | 2.3 | 2.0 | 2.1 | 1.9 | 1.7 |
| History of peripheral artery disease | 7.4 | 7.4 | 7.2 | 6.8 | 8.7 | 8.8 | 8.4 | 8.6 |
| History of HF | 26.4 | 25.8 | 25.7 | 25.0 | 26.0 | 26.5 | 27.0 | 27.4 |
| History of CKD | 19.1 | 20.4 | 21.2 | 21.7 | 23.4 | 25.3 | 25.9 | 28.1 |
| History of dementia | 6.3 | 6.7 | 6.7 | 6.7 | 7.4 | 5.7 | 5.1 | 4.6 |
| Depression | 20.2 | 19.5 | 19.8 | 19.8 | 21.1 | 21.2 | 21.8 | 22.4 |
| Taking antihypertensive medication | ||||||||
| No | 33.8 | 34.6 | 35.7 | 36.2 | 35.9 | 35.9 | 35.7 | 34.6 |
| Yes, with low adherence | 14.8 | 14.6 | 14.2 | 14.0 | 14.1 | 13.9 | 13.0 | 12.5 |
| Yes, with high adherence | 51.4 | 50.8 | 50.1 | 49.8 | 50.0 | 50.2 | 51.3 | 52.9 |
| Taking nonstatin lipid‐lowering medication | 13.3 | 9.4 | 8.7 | 8.6 | 8.0 | 7.3 | 7.0 | 7.1 |
| Postindex statin fill characteristics, % | ||||||||
| New diagnosis of CHD | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| New diagnosis of DM | 2.0 | 1.9 | 1.8 | 1.7 | 1.6 | 1.4 | 1.5 | 1.5 |
| New diagnosis of stroke | 1.3 | 1.6 | 1.4 | 1.4 | 1.3 | 1.2 | 1.2 | 1.3 |
| New diagnosis of HF | 6.3 | 6.5 | 6.1 | 5.5 | 5.3 | 5.3 | 5.1 | 5.6 |
| New diagnosis of CKD | 4.1 | 4.0 | 4.3 | 4.2 | 3.9 | 4.0 | 4.1 | 4.3 |
| New diagnosis of dementia | 1.7 | 1.6 | 1.7 | 1.7 | 1.4 | 1.5 | 1.5 | 1.5 |
| Cardiologist care | 74.2 | 75.3 | 75.5 | 75.7 | 75.9 | 77.9 | 78.2 | 79.3 |
| Number of medications taken | ||||||||
| <5 | 9.8 | 10.8 | 11.2 | 11.8 | 11.8 | 11.4 | 11.4 | 10.8 |
| 5–9 | 45.6 | 45.3 | 46.4 | 46.1 | 45.9 | 45.8 | 44.7 | 44.8 |
| ≥10 | 44.6 | 43.9 | 42.4 | 42.1 | 42.4 | 42.9 | 43.9 | 44.5 |
CHD indicates coronary heart disease; CKD, chronic kidney disease: DM, diabetes mellitus; HF, heart failure; MI, myocardial infarction.
*
Limited to patients in Medicare.